Medical Doctor Program year 2022 Reported 2019–2022 Source: CMS Open Payments, 2026 publication

Javier Sobrado

Gastroenterology Miami, FL Medical Doctor

NPI 1689636391 CMS profile 257497

8525 Sw 92Nd St, Suite D-17, Miami, FL 33156

Open in the dashboard

General payments

$8,566

362 records reported · program years 2019–2022

Research payments

$16,439

Paid to them · 10 records reported · program years 2019–2022

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,439,626 paid to institutions, not to them · program years 2019–2025

Through program year 2022, Javier Sobrado of Miami, FL is reported in the CMS Open Payments database as having received $8,566 across 362 general payments and $16,439 in research payments paid to them. Separately, studies naming them as principal investigator received $1,439,626 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 90th percentile of Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $1,378 62
2021 General $1,893 99
2021 Research $398 1
2020 General $1,868 58
2020 Research $3,705 4
2019 General $3,426 143
2019 Research $12,336 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Javier Sobrado
  • Gastroenterology median
  • Middle half of Gastroenterology
  • National median

In program year 2025, general payments to Javier Sobrado were reported at $0. Among 13,050 Gastroenterology profiles paid that year, the median was $639 and the middle half received between $167 and $1,700.

Show as a table
Year Javier Sobrado Gastroenterology median Middle half National median
2019 $3,426 $417 $126–$1,100 $163
2020 $1,868 $224 $74–$624 $114
2021 $1,893 $352 $106–$1,054 $132
2022 $1,378 $448 $129–$1,270 $149
2023 $0 $533 $150–$1,390 $160
2024 $0 $605 $160–$1,606 $164
2025 $0 $639 $167–$1,700 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. GI Supply, Inc. $2,100 3 payments
  2. AbbVie, Inc. $1,792 88 payments
  3. Salix Pharmaceuticals, a division of Bausch Health US, LLC $1,116 84 payments
  4. QOL Medical, LLC $626 44 payments
  5. Takeda Pharmaceuticals U.S.A., Inc. $501 29 payments
  6. Nestle HealthCare Nutrition Inc. $327 10 payments
  7. Gilead Sciences, Inc. $248 13 payments
  8. Janssen Biotech, Inc. $225 15 payments
  9. Intercept Pharmaceuticals, Inc. $224 10 payments
  10. Braintree Laboratories, Inc. $176 12 payments
  11. Other $1,229 54 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Food and Beverage $6,480 357 payments
  2. Honoraria $2,013 2 payments
  3. Gift $53 1 payment
  4. Education $19 2 payments
Products named General payments · program years 2019–2022
  1. XIFAXAN $1,066 80 payments
  2. MAVYRET $770 36 payments
  3. Sucraid $626 44 payments
  4. HUMIRA $505 25 payments
  5. LINZESS $334 18 payments
  6. ZENPEP $327 10 payments
  7. STELARA $264 17 payments
  8. CREON $262 15 payments
  9. Entyvio Lower GI $226 16 payments
  10. ENTYVIO Internal Medicine $161 6 payments
  11. Other $2,361 126 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2022
  1. Eli Lilly and Company $9,439 9 payments
  2. Celltrion, Inc. $7,000 1 payment

Records

372 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gastroenterology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record